Were Hedge Funds Right About Piling Into AbbVie Inc (ABBV)?
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Posts Tagged ‘NYSE:ABBV’
Trumpdesivir: Operation Warp Speed, “Engage.”
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (...
Hedge Funds Have Never Been This Bullish On AbbVie Inc (ABBV)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Were Hedge Funds Right About AbbVie Inc (ABBV)?
We hate to say this but, we told you so.
Hedge Fund and Insider Trading News: Philip Falcone, George Soros, Bill Ackman, Impala Asset Management, AbbVie Inc (ABBV), Range Resources Corp. (RRC), and More
BOSTON (Reuters) - An activist investor is stepping up calls for the board of HC2 Holdings Inc (HCHC.N) to remove Chief Executive and Chairman Philip Falcone as the former hedge...
Should You Buy AbbVie Inc (ABBV)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
How Did AbbVie Inc (ABBV) Perform In Comparison to Hedge Fund Favorites in 2019?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged in 2019.
Did Hedge Funds Drop The Ball On AbbVie Inc (ABBV) ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Were Hedge Funds Right About Snapping Up AbbVie Inc (ABBV)?
We can judge whether AbbVie Inc (NYSE:ABBV) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Hedge Fund and Insider Trading News: T. Boone Pickens, Carl Icahn, Glen Kacher, Camber Capital Management, Elliott Management, Abbvie Inc. (ABBV), Fidelity National Financial Inc (FNF), and More
In a message he wrote shortly before his death, the legendary oil magnate T.
Are Hedge Funds Going To Get Burned By AbbVie Inc (ABBV) ?
"The end to the U.S. Government shutdown, reports of progress on China-U.S.
Were Hedge Funds Right About AbbVie Inc (ABBV)?
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter.
Is AbbVie Inc (ABBV) A Good Stock To Buy?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics ...
20 Dividend Stocks That Billionaires Are Piling On
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher's favorite dividend ...
Hedge Fund and Insider Trading News: George Soros, Paulson & Co., AbbVie Inc (ABBV), Seagate Technology PLC (STX), Alliance Data Systems Co. (ADS), and More
Although billionaire superinvestor George Soros may no longer be running the day-to-day operations of his namesake fund "Soros Fund Management," the fund's quarterly activity ...
Market Movers Today: Omeros Corporation (OMER), AbbVie Inc (ABBV), Darden Restaurants, Inc. (DRI), Odyssey Marine Exploration Inc (OMEX), and More
Omeros Corp. OMER, +36.60% shares surged 45% in extremely heavy morning trade Thursday on a new government spending bill that benefits its cataract surgery drug Omidria.
Hedge Fund and Insider Trading News: Elliott Management, Marcato Capital Management, CBRE Group Inc (CBG), AbbVie Inc (ABBV), Neogen Corporation (NEOG), and More
Billionaire Paul Singer’s Elliott Management Corp. has bought a stake in Wipro Ltd., its first ever purchase of an Indian-based software outsourcer.
Flowhub is Automating Cannabis From Seed to Sale
There is no doubt that the marijuana industry in the US has a lot of growth potential.
Look Beyond Pharma to Invest in Marijuana Industry
In this article we are going to present an alternative to weed stocks such as GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Cara Therapeutics Inc (NASDAQ:CARA), Zynerba Pharmaceuticals...
Market Movers Today: AbbVie Inc (ABBV), Intel Corporation (INTC), Wynn Resorts, Limited (WYNN), and More
AbbVie, the maker of the world's best selling drug, reported fourth-quarter profit on Friday that beat Wall Street estimates on strong sales for its blockbuster drug Humira.
This Is How To Invest in the Marijuana Industry
Marijuana industry in the US is still in its inception phase, but it’s growing, and the projections are very optimistic.
True Leaf Seeks to Raise Capital as It Prepares to Enter into the Booming Canadian Marijuana Market
Canada is undoubtedly one of the greatest countries on earth.
15 Best Selling Most Profitable Drugs of All Time
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Top 75 Healthcare Dividend Stocks To Invest In
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
15 Biggest Healthcare Companies in USA
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies...
This Fund’s Picks Gained 200% In A Year And Why No One Knows About It
You probably haven't heard of Alex Denner's Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which its stock picks in companies valued...
10 Most Advanced Technologies In The World Today
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators.
In A Blow To AbbVie Inc (ABBV) Humira, Market For Biosimilars Opened Wide
Two patents that AbbVie Inc (NYSE:ABBV) held on Humira, a treatment for arthritis, have been invalidated by an English court.
AbbVie Inc (ABBV) In Share Buyback Plan For The Third Year In A Row
The AbbVie Inc (NYSE:ABBV) board of directors has given the authorization required to increase $5 billion to the company’s existing share buyback program.
UK National Institute For Health And Care Excellence Rejects Leukemia Drug From AbbVie Inc (ABBV)
The National Institute for Health and Care Excellence has refused to authorize AbbVie Inc (NYSE:ABBV)'s Venclyxto on NHS.
Here’s What’s Important About The Latest AbbVie Inc (ABBV) Approval
AbbVie Inc (NYSE:ABBV) just announced that it has picked up approval for one of its lead development candidates, but the company has failed to really move on the announcement.
12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies.
Emergent Technologies’ Pure MHC Explores A New Collaboration With AbbVie Inc (ABBV)
AbbVie Inc (NYSE:ABBV) has sought a joint venture with its target discovery portfolio company, Emergent Technologies Inc, Pure MHC.
Mylan NV (MYL), AbbVie Inc (ABBV) Sanofi SA (ADR) (SNY) In Spotlight Over Price Hikes
A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations.
Billionaire Druckenmiller’s Top Dividend Stock Picks
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros.
AbbVie Inc (ABBV) Awaits NDA Approval For Hepatitis C Treatment
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration.
Billionaire Larry Robbins Knows How To Pick Mega-Cap Stocks
Larry Robbins’ Glenview Capital Management reported an equity portfolio worth over $13.98 billion in its latest 13F filing.
Billionaire Larry Robbins Confidently Piles Into CBS, Anthem, As Merger Battles Continue
Larry Robbins is a billionaire investor and businessman who founded the New York-based hedge fund Glenview Capital in 2000. Mr.
Is AbbVie Inc (ABBV) A Good Stock To Buy?
Hedge funds are not perfect. They have their bad picks just like everyone else.
Gilead Sciences, Inc. (GILD) Takes Lead Against AbbVie Inc (ABBV) On Crohn’s Disease Treatment
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (NASDAQ:GLPG).
December 2016 Stock Considerations
The final ‘stock considerations’ post of 2016 is finally at hand.
AbbVie Inc (ABBV), Alkermes PLC (ALKS): Will Woodford Investment’s Long Positions Rule the Market Again in Q4?
Woodford Investment Management is a London-based hedge fund founded in 2016 by Neil Woodford.
AbbVie Inc (ABBV) Wins Patent Battle Against Coherus Biosciences Inc (CHRS)
The US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) has decided not to embark on the review of the 166 formulation patent of AbbVie Inc (NYSE:ABBV) ...
AbbVie Inc (ABBV) Stock: Skyrocketing On IP Chatter | Coherus Biosciences Inc (CHRS) Stock Tanking
AbbVie Inc (NYSE:ABBV) and Coherus Biosciences Inc (NASDAQ:CHRS) were both off to a relatively normal start in the market today.
November 2016 Stock Considerations
As we near the home stretch of 2016 it seems like Mr. Market wants to give us some better buying opportunities compared to the recent months that have passed.
Trending Stocks: Davita, Nordstrom, AbbVie, and More
Among the stocks that are capturing investors' attention today are Nordstrom, Inc. (NYSE:JWN), AbbVie Inc (NYSE:ABBV), AutoNation, Inc.
Four Dividend Champions On Sale
I usually look at dividend growth stocks and their dividend increases every week, as part of my portfolio monitoring process.
Recent Stock Purchase II October 2016
I always end my ‘Recent Buys’ posts with the caveat that Mr. Market can always spring up some new opportunities not outlined in my monthly considerations posts.
